These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10585499)

  • 1. Analysis of heregulin symmetry by weighted evolutionary tracing.
    Landgraf R; Fischer D; Eisenberg D
    Protein Eng; 1999 Nov; 12(11):943-51. PubMed ID: 10585499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-terminal charge affects the periplasmic accumulation of recombinant heregulin/EGF hybrids exported using the Escherichia coli alkaline phosphatase signal sequence.
    Campion SR; Elsasser E; Chung R
    Protein Expr Purif; 1997 Aug; 10(3):331-9. PubMed ID: 9268680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1.
    Landgraf R; Pegram M; Slamon DJ; Eisenberg D
    Biochemistry; 1998 Mar; 37(9):3220-8. PubMed ID: 9485477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution solution structure of the EGF-like domain of heregulin-alpha.
    Jacobsen NE; Abadi N; Sliwkowski MX; Reilly D; Skelton NJ; Fairbrother WJ
    Biochemistry; 1996 Mar; 35(11):3402-17. PubMed ID: 8639490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a heregulin binding site in HER3 extracellular domain.
    Singer E; Landgraf R; Horan T; Slamon D; Eisenberg D
    J Biol Chem; 2001 Nov; 276(47):44266-74. PubMed ID: 11555649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells.
    Ram TG; Hosick HL; Ethier SP
    J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor contains both positive and negative determinants for interaction with ErbB-2/ErbB-3 heterodimers.
    Stortelers C; van De Poll ML; Lenferink AE; Gadellaa MM; van Zoelen C; van Zoelen EJ
    Biochemistry; 2002 Apr; 41(13):4292-301. PubMed ID: 11914075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of EGFR family-mediated HRG signals in human ovarian cancer.
    Campiglio M; Ali S; Knyazev PG; Ullrich A
    J Cell Biochem; 1999 Jun; 73(4):522-32. PubMed ID: 10733345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin reverses the oligomerization of HER3.
    Landgraf R; Eisenberg D
    Biochemistry; 2000 Jul; 39(29):8503-11. PubMed ID: 10913256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4.
    Nagata K; Kohda D; Hatanaka H; Ichikawa S; Matsuda S; Yamamoto T; Suzuki A; Inagaki F
    EMBO J; 1994 Aug; 13(15):3517-23. PubMed ID: 8062828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heregulins implicated in cellular functions other than receptor activation.
    Breuleux M; Schoumacher F; Rehn D; Küng W; Mueller H; Eppenberger U
    Mol Cancer Res; 2006 Jan; 4(1):27-37. PubMed ID: 16446404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
    Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J
    Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EGF receptor binding of recombinant heregulinbeta1/EGF hybrids is blocked by heregulin residue glutamate 195.
    Chau BN; Nandagopal K; Niyogi SK; Campion SR
    Biochem Biophys Res Commun; 1996 Dec; 229(3):882-6. PubMed ID: 8954988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Backbone dynamics of the EGF-like domain of heregulin-alpha.
    Fairbrother WJ; Liu J; Pisacane PI; Sliwkowski MX; Palmer AG
    J Mol Biol; 1998 Jun; 279(5):1149-61. PubMed ID: 9642091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evolution of the EGF-CFC protein family.
    Ravisankar V; Singh TP; Manoj N
    Gene; 2011 Aug; 482(1-2):43-50. PubMed ID: 21640172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3.
    Chen CH; Chernis GA; Hoang VQ; Landgraf R
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9226-31. PubMed ID: 12874383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
    Ram TG; Kokeny KE; Dilts CA; Ethier SP
    J Cell Physiol; 1995 Jun; 163(3):589-96. PubMed ID: 7775601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct characteristics of heregulin signals mediated by HER3 or HER4.
    Weiss FU; Wallasch C; Campiglio M; Issing W; Ullrich A
    J Cell Physiol; 1997 Nov; 173(2):187-95. PubMed ID: 9365520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display.
    Stortelers C; Souriau C; van Liempt E; van de Poll ML; van Zoelen EJ
    Biochemistry; 2002 Jul; 41(27):8732-41. PubMed ID: 12093292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.